Search - tctmd.com

Displaying 781 - 800 of 810

Sort: Relevancy | Date

Presentation

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Presenter: Hans-Christoph Diener

March 08, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

Caitlin E. Cox

March 06, 2012

News Daily News

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Caitlin E. Cox

March 06, 2012

Presentation

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Presenter: S. Friedland

March 06, 2012

Presentation

Meta-Análisis of Ensayos Controlados Aleatorizaos sobre el Efecto del Cilostazol en la Re-estenosis y Resultados tras PCI

Presenter: S. Friedland

March 06, 2012

Presentation ISET 2012

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Presenter: Gunnar Tepe

January 17, 2012

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

Presentation

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Presenter: B.J. Kim

January 12, 2012

Presentation

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Presenter: B.J. Kim

January 12, 2012

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Yael L. Maxwell

September 26, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

Advertisement

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Meta-Análisis of Ensayos Controlados Aleatorizaos sobre el Efecto del Cilostazol en la Re-estenosis y Resultados tras PCI

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Six Months Sufficient for Dual Antiplatelet Therapy

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Long-term Antiplatelet Therapy: All Risk, No Benefit

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content